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Introduction {#sec005}
============

The number of people living with hypertension is predicted to be 1.56 billion worldwide by the year 2025\[[@pone.0187240.ref001]\]. In addition, hypertension contributes to \~13% of the total mortality worldwide\[[@pone.0187240.ref002]\] and \~7% of the total disability-adjusted life years, creating a tremendous financial burden for both patients and the health-care system\[[@pone.0187240.ref002]\]. The association between hypertension and traditional risk factors such as age, body mass index (BMI), blood pressure (BP), smoking and family history have been well studied, whereas the roles of genetic variants associated with the incidence of hypertension are less clearly defined\[[@pone.0187240.ref003],[@pone.0187240.ref004]\].

In 2013, Echouffo-Tcheugui JB *et al*. published a systematic review of 11 articles with 15 models\[[@pone.0187240.ref005]\]. Most of these models were carried out in Caucasian populations, and the prediction factors used in these studies were almost identical. Noticeably, none of the above models took genetic factors into consideration, whereas in recent years, more study designs of hypertension risk prediction models have tended not only to have larger patient enrollment size with diverse ethnic backgrounds but also to include genetic factors in these models. Therefore, we conducted this systematic review to summarize the current development status and performance of hypertension prediction models, which would provide updates for health-care providers and policy-makers in the field of hypertension research and clinical practice. This review could also help improve hypertension awareness, identify populations at high risk for hypertension, and determine those individuals who could benefit from early interventions.

Method {#sec006}
======

Search strategy {#sec007}
---------------

The research strategy, study selection and analysis methods used in this study followed the guidelines from the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) Statement\[[@pone.0187240.ref006]\] ([S1 Table](#pone.0187240.s002){ref-type="supplementary-material"}). We conducted a complete literature search in both PubMed and Embase to retrieve all published reports about hypertension prediction models using the keywords "hypertension", "high blood pressure", "prediction model", and "risk score". The search strategy was (((prediction model\[Title/Abstract\]) OR risk score)) AND ((hypertension\[Title/Abstract\]) OR high blood pressure\[Title/Abstract\]). The last search was conducted on September 5, 2016. The related references from those retrieved reports were also searched manually to identify any additional published reports. For those identified articles that were not available online, we contacted the authors directly to request copies.

Inclusion and exclusion criteria {#sec008}
--------------------------------

All the retrieved reports were screened independently for inclusion by two researchers from this study. The titles and abstracts of retrieved papers were used as the primary review content for inclusion verification. However, if questioned or unclear, the full article was reviewed prior to inclusion decision. The study's inclusion criteria include: 1. Reporting a risk assessment tool, e.g., an equation or a risk score system; 2. Predicting the risk incidence of essential hypertension; 3. Published in English-language journals; 4. Conducted in subjects 18 years old or older; 5. Reporting quantitative measures of model performance (preferred but not necessarily required). Exclusion criteria include: 1. Studies only describe association between risk factors and incident hypertension; 2. Simulation studies; 3. Studies predict gestation-related hypertension; 4. Unpublished research data.

Data extraction and synthesis {#sec009}
-----------------------------

Any discrepancy of the independently collected data from the two researchers was resolved by group discussion among all participating project investigators. The following data were extracted from each study: study design, subject characteristics, number of subjects in derivation and validation cohorts, number of subjects who developed hypertension, number of candidate variables considered, variables included in the final model and statistical method used for development of the model. We extracted the area under the curve (AUC) of the receiver operating characteristic or C-statistic to assess the discrimination ability of each model. We also collected the value of Hosmer--Lemeshow χ^2^, and the *p* value of the corresponding test statistic, to assess model calibration ability. Due to the wide spread of differences in risk factors, population, study design, and sufficiency of data, it was impossible to perform meta-analysis in our current study. Instead, we opted to conduct a narrative synthesis of the evidence. However, to provide a nice summary graph, we applied the random effects model meta-analysis to combine the estimates of the AUC from studies with enough data and assessed the between-study heterogeneity, with the use of the Stata statistical software version 12.0(<http://www.stata.com/>). The data used in meta-analysis was transformed in the way of double arcsine transformations to addresses the problems of confidence limits and variance instability. The potential publication bias was assessed with funnel plot, as well as Begg\'s and Egger's test. A P value \<.05 indicated significant publication bias.

Results {#sec010}
=======

The process of the literature search and paper selection, according to PRISMA guidelines, is presented in [Fig 1](#pone.0187240.g001){ref-type="fig"}. Our initial literature search resulted in 7332 citations; only 26 articles were selected, reporting 48 prediction models. [Table 1](#pone.0187240.t001){ref-type="table"} shows the characteristics of these 26 studies, of which 5 were conducted in the US\[[@pone.0187240.ref007]--[@pone.0187240.ref011]\], 5 in Europe\[[@pone.0187240.ref012]--[@pone.0187240.ref016]\], 7 in China\[[@pone.0187240.ref017]--[@pone.0187240.ref023]\], 4 in Korea\[[@pone.0187240.ref024]--[@pone.0187240.ref027]\], 2 in Japan\[[@pone.0187240.ref028],[@pone.0187240.ref029]\], 2 in Iran\[[@pone.0187240.ref030],[@pone.0187240.ref031]\], and 1 in India\[[@pone.0187240.ref032]\]. Among them, only 1 study was carried out in women alone\[[@pone.0187240.ref009]\]. A total of 162,358 subjects were enrolled in these studies. In the longitudinal studies, participants were followed up for 3 to 30 years. The definition of hypertension among these studies was consistent. Twenty-four studies defined hypertension as either systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg, or the use of antihypertensive drugs. Two studies\[[@pone.0187240.ref017],[@pone.0187240.ref031]\] defined isolated systolic hypertension as SBP ≥140 mmHg and DBP ≤ 90 mmHg, and isolated diastolic hypertension as DBP ≥ 90 mmHg and SBP ≤ 140 mmHg. Twenty studies used traditional factors only, and 6 studies\[[@pone.0187240.ref011],[@pone.0187240.ref014],[@pone.0187240.ref016],[@pone.0187240.ref019],[@pone.0187240.ref021],[@pone.0187240.ref026]\] also included Genetic Risk Score (GRS) factors (indeed, 2 studies\[[@pone.0187240.ref019],[@pone.0187240.ref026]\] used genetic risk factors exclusively). The common predictors included in most models were age, gender, BMI, SBP, DBP, and parental history of hypertension. The SNPs that were used for setting up the GRS system were nearly all derived from the genome-wide association study (GWAS). The number of SNPs used in these studies ranged from 2 to 32 ([S2 Table](#pone.0187240.s003){ref-type="supplementary-material"}). The AUC or C-statistic of models\[[@pone.0187240.ref011],[@pone.0187240.ref021]\] including GRS were superior compared to those without GRS (C-index change = 0.3%--0.5%; *p*\<0.05). Twelve studies proposed to build models with logistic regression, 7 with COX regression, 6 with Weibull regression, and 1 with linear regression.

![The process of article search and selection.\
*From*: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). *P*referred *R*eporting *I*terns for *S*ystematic Reviews and *M*eta-*A*nalyses: The PRISMA Statement. PLoS Med 6(6): e1000097. doi:[10.1371/joumal.pmed1000097](https://doi.org/10.1371/joumal.pmed1000097). **For more information, visit** [www.prisma-statement.org](http://www.prisma-statement.org)**.**](pone.0187240.g001){#pone.0187240.g001}
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###### Characteristics of included articles.

![](pone.0187240.t001){#pone.0187240.t001g}

  First author                Year   Country/Ethnicity          Study design         Outcomes/total                                      Age                                           Definition of hypertension                                                                                                                                                                           Follow up (years)   Type of statistic
  --------------------------- ------ -------------------------- -------------------- --------------------------------------------------- --------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------- -----------------------------------------------
  Pearson                     1990   USA/Mixed, mainly Whites   Prospective          104/1130                                            25 or less                                    Self-reported use of BP lowering medications [^c^](#t001fn004){ref-type="table-fn"}                                                                                                                  30                  Cox regression analysis
  Chih-Jung Yeh               2001   China/Taiwan               prospective          87/2373                                             ≥20                                           SBP≥ 140 mmHg and DBP\< 90 mmHg [^b^](#t001fn003){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}                                                                                         3.23                Cox regression analysis
  Nisha I. Parikh             2008   American/whites            prospective          796/1717                                            20 to 69                                      JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}[^d^](#t001fn005){ref-type="table-fn"}                                                                                                    4                   Weibull regression model
  Nina P. Paynter             2009   American/mainly whites     prospective          derivation 1935/9427; validation 1068/5395          45 and older, females only                    Self-report or SBP≥140 mmHg or DBP≥90 mmHg[^a^](#t001fn002){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}                                                                               8                   Logistic regression
  Mika Kivimäki               2009   England/mainly whites      prospective          1258/8207                                           35 to 68                                      JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}                                                                                                                                          5                   Weibull regerssion
  Mika Kivimäki               2010   England/mainly whites      prospective cohort   derivation 614/4135; validation 438/2785            35 to 68                                      JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}                                                                                                                                          5                   Weibull regression
  Abhijit V. Kshirsagar       2010   American/whites            prospective          3795/11407                                          45 to 64                                      JNC---VII definition [^c^](#t001fn004){ref-type="table-fn"}                                                                                                                                          9                   multiple logistic regression
  Mohammadreza Bozorgmanesh   2011   Iran/Asians                prospective          805/4656                                            42                                            the average of two DBP measurements≥90 mmHg or the average of two SBP ≥140 mmHg or taking antihypertension medication [^b^](#t001fn003){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}   6                   Weibull proportional hazard regression models
  K-L Chien                   2011   China/Taiwan               prospective          1029/2506                                           ≥35                                           JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}                                                                                                                                          6.15                multivariate Weibull model
  Cristiano Fava              2013   Sweden/whites              prospective          NR/10781                                            NR                                            JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}                                                                                                                                          23                  Multiple linear and logistic regression
  Nam-Kyoo Lim                2013   Korean/Asians              prospective          819/4747                                            40 to 69                                      JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}                                                                                                    4                   Weibull regression analysis
  Henry                       2013   Northeast Germany/whites   prospective          training set 166/803; validation set 157/802        20--79                                        SBP/DBP≥140/90 mmHg [^b^](#t001fn003){ref-type="table-fn"}                                                                                                                                           5                   Bayesian networks
  Li Guoqi                    2014   China/Asians               prospective          1776/3899                                           35--64                                        nr                                                                                                                                                                                                   15                  logistic regression
  Yun-Hee Choi                2014   Mexican Americans          prospective          nr/443                                              nr                                            JNC---VII definition                                                                                                                                                                                 nr                  generalized estimating equations method
  Yue Qi                      2014   China/Asians               case control         1009 with hypertension; 756 normotensive controls   case cohort 64.48±8.53; control 64.23±10.13   JNC---VII definition [^a^](#t001fn002){ref-type="table-fn"}                                                                                                                                          nr                  logistic regression
  Bum Ju Lee                  2014   Korea/Asians               cross-sectional      12789                                               21--85                                        SBP/DBP≥140/90 mmHg or physician-diagnosed hypertension                                                                                                                                              nr                  correlation-based feature selection
  Nam-Kyoo Lim                2015   Korean/Asians              prospective          nr/5632                                             40 to 69 years                                JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}                                                                                                    4                   logistic regression
  Toshiaki Otsuka             2015   Japan/Asians               prospective          1633/15025                                          38.8±8.9                                      JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}                                                                                                                                          4                   Cox proportional hazards model
  Xiangfeng Lu                2015   China/Asians               prospective          2559/7724                                           35 to 74                                      JNC---VII definition [^a^](#t001fn002){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}                                                                                                    7.9                 logistic regression
  Wenchao Zhang               2015   China/Asians               prospective          3793/17471                                          18 to 88                                      JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}                                                                                                    5                   Cox proportional hazards regression model
  Minoru Yamakado             2015   Japan/Asians               prospective          424/2637                                            55.2                                          JNC---VII definition [^d^](#t001fn005){ref-type="table-fn"}                                                                                                                                          4                   logistic regression analysis
  Joung-Won Lee               2015   Korea/Asians               prospective          2128 men and 2326 women                             40--69                                        JNC---VII definition [^a^](#t001fn002){ref-type="table-fn"}[^d^](#t001fn005){ref-type="table-fn"}                                                                                                    4                   Cox proportional hazard model
  Samaneh Asgari              2015   Tehran/Asians              prospective          235/4574                                            ≥20                                           SBP≥140 mmHg and DBP\<90 mmHg [^b^](#t001fn003){ref-type="table-fn"}[^d^](#t001fn005){ref-type="table-fn"}                                                                                           9.57                Cox proportional hazard regression
  Samaneh Asgari              2015   Tehran/Asians              prospective          470/4809                                            ≥20                                           SBP\<140 mmHg and DBP ≥90 mmHg [^b^](#t001fn003){ref-type="table-fn"}[^d^](#t001fn005){ref-type="table-fn"}                                                                                          9.62                Cox proportional hazard regression
  Thirunavukkarasu Sathish    2016   India/blacks               prospective          70/297                                              15--64                                        JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}                                                                                                                                          7.1                 logistic regression model
  Teemu J. Niiranen           2016   Finland/whites             prospective          nr/2045                                             ≥30                                           JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}                                                                                                    11                  Multiple linear and logistic regression
  Chen, Y.                    2016   China/Chinese              prospective          2785/12497                                          40.84±11.34                                   JNC---VII definition [^b^](#t001fn003){ref-type="table-fn"}[^c^](#t001fn004){ref-type="table-fn"}                                                                                                    4                   multivariable backward Cox analyses

Study design is prospective study or cross-sectional study; Outcomes/total means the number of incident hypertension and the total number of participants of each study; Age is expressed as the mean value or range; BP is blood pressure, SBP means systolic blood pressure and DBP means diastolic blood pressure; JNC---VII definition means the definition of hypertension is based on the Joint National Committee (JNC)---VII definition of hypertension (i.e., SBP/DBP ≥140/90 mmHg or use of antihypertension medications).

^a^ means one-time BP measurement was used to define hypertension;

^b^ for average of multiple BP measurements;

^c^ means patient reported anti-hypertensive drugs;

^d^ for abstracted from chart;

First author and year represent study.

Performance of prediction models {#sec011}
--------------------------------

The performance of prediction models is shown in [Table 2](#pone.0187240.t002){ref-type="table"}. AUC ranged from 0.64 to 0.97, and C-statistic ranged from 60% to 90%. The results of pooling 35 models in meta-analysis([S1 File](#pone.0187240.s005){ref-type="supplementary-material"}) show the value of AUC as 0.767, 95%CI(0.742, 0.792). The calibration was assessed by Hosmer--Lemeshow χ^2^, suggesting that these models had good calibration ability.

10.1371/journal.pone.0187240.t002

###### Characteristics of prediction models.

![](pone.0187240.t002){#pone.0187240.t002g}

  First author                Year   Model name                                              Candidate variables (n)   Variables include                                                                                                                                                                                                                                                           AUC/C-statistic                                                                                                               Calibration                                                                                          Method of validation
  --------------------------- ------ ------------------------------------------------------- ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- -----------------------------------------------
  Pearson                     1990   Johns Hopkins                                           NR                        Age, SBP at baseline, paternal history of hypertension and BMI                                                                                                                                                                                                              NR                                                                                                                            NR                                                                                                   NR
  Chih-Jung Yeh               2001   ISH risk prediction model                               NR                        age, DM, and fibrinogen concentration in men, and age and APTT (activated partial thromboplastin time) in women                                                                                                                                                             NR                                                                                                                            NR                                                                                                   NR
  Chih-Jung Yeh               2001   IDH risk prediction model                               NR                        elevated BMI, glucose concentration, and uric acid concentration were significant factors in men; BMI was the only significant factor in women.                                                                                                                             NR                                                                                                                            NR                                                                                                   NR
  Nisha I. Parikh             2008   Framingham risk score                                   11                        age, sex, SBP, DBP, BMI, parental hypertension, and cigarette smoking                                                                                                                                                                                                       NR/0.788,95% CI(0.733, 0.803)                                                                                                 Hosmer--Lemeshow χ^2^ = 4.35                                                                         NR
  Nina P. Paynter             2009   WHS inclusive risk prediction                           14                        age, BP, BMI, total grain intake, apolipoprotein B, ethnicity, lipoprotein(a), C-reactive protein                                                                                                                                                                           NR/0.705                                                                                                                      Hosmer--Lemeshow χ^2^ = 2.9(P = 0.94)                                                                Internal validation, split-sample 2:1
  Nina P. Paynter             2009   WHS Simplified Model with Lipids                        23                        Age, BMI, SBP, DBP, ethnicity (Black or Hispanic) and total to HDL- cholesterol ratio                                                                                                                                                                                       NR/0.705                                                                                                                      Hosmer-Lemeshow χ^2^ = 9.4(P = 0.31)                                                                 Internal validation, split-sample 2:1
  Nina P. Paynter             2009   WHS Simplified Model                                    23                        Age, BMI, race/ethnicity, SBP, and DBP                                                                                                                                                                                                                                      NR/0.703                                                                                                                      Hosmer--Lemeshow χ^2^ = 6.0(P = 0.64)                                                                Internal validation, split-sample 2:1
  Mika Kivimäki               2009   Whitehall II risk score                                 NR                        Age, sex, SBP, DBP, BMI, parental hypertension and cigarette smoking                                                                                                                                                                                                        NR/0.80                                                                                                                       Hosmer--Lemeshow χ^2^ = 11.5(\<20)                                                                   Internal validation, split-sample (6:4)
  Mika Kivimäki               2010   Whitehall II Repeat measures risk score                 NR                        repeat measures of BP, weight and height, current cigarette smoking and parental history of hypertension                                                                                                                                                                    NR/0.799                                                                                                                      predicted-to-observed ratio 0.98, 95% CI(0.89, 1.08). Hosmer--Lemeshow χ^2^ = 6.5                    Internal validation, split-sample
  Mika Kivimäki               2010   the average blood pressure risk score                   NR                        average BP, weight and height, current cigarette smoking and parental history of hypertension                                                                                                                                                                               NR/0.794                                                                                                                      predicted-to-observed ratio 0.96, 95%CI (0.88, 1.06)                                                 Internal validation, split-sample
  Mika Kivimäki               2010   the 'usual' blood pressure risk score                   NR                        the 'usual' BP, weight and height, cigarette smoking and parental history of hypertension                                                                                                                                                                                   NR                                                                                                                            NR                                                                                                   Internal validation, split-sample
  Abhijit V. Kshirsagar       2010   ARIC/CHC risk score                                     11                        Age, level of SBP or DBP, smoking, family history of hypertension, diabetes mellitus, high BMI, female sex, and lack of exercise                                                                                                                                            0.739 (3years), 0.755 (6 years), 0.800 (9 years) and 0.782 (ever)/nr                                                          NR                                                                                                   Internal validation, split-sample
  Mohammadreza Bozorgmanesh   2011   TLGS risk multivariable models                          NR                        for women: age, waist circumference, DBP, SBP, and family history of premature CVD; for men: age, DBP, SBP, and smoking; for both: the interaction terms between age and SBP, Increasing levels of SBP                                                                      NR/0.731 (95% CI 0.706--0.755) for women; 0.741 (95% CI 0.719--0.763) for men                                                 women (Hosmer--Lemeshow χ^2^ = 7.8, P = 0.554) and men (Hosmer--Lemeshow χ^2^ = 8.8, P = 0.452).     NR
  Mohammadreza Bozorgmanesh   2011   TLGS risk score                                         NR                        Waist circumference, DBP, family history of premature cardiovascular disease, daily smoking, SBP                                                                                                                                                                            NR/0.727 (95% CI 0.709--0.744)                                                                                                NR                                                                                                   NR
  K-L Chien                   2011   Taiwan BP clinical risk model                           NR                        gender, age, BMI, SBP and DBP                                                                                                                                                                                                                                               0.732,95% CI (0.712,0.752)/NR                                                                                                 Hosmer--Lemeshow χ^2^ = 8.3, p = 0.40                                                                NR
  K-L Chien                   2011   Taiwan BP clinical risk model                           NR                        gender, age, BMI, SBP and DBP, white blood count, fasting glucose and uric acid                                                                                                                                                                                             0.735,95% CI (0.715--0.755)/NR                                                                                                Hosmer--Lemeshow χ^2^ = 13.2, p = 0.11                                                               NR
  Cristiano Fava              2013   Swedish nongenetic risk model                           NR                        age, sex, age^2^, sex times age, heart rate, obesity, diabetes, hypertriglyceridemia, prehypertension, family history of hypertension, sedentary in spare time, problematic alcohol behavior, married or living as a couple, high-level non-manual work, smoking            NR/0.662                                                                                                                      NR                                                                                                   NR
  Cristiano Fava              2013   Swedish genetic risk model                              29                        29 SNPs                                                                                                                                                                                                                                                                     NR                                                                                                                            NR                                                                                                   NR
  Cristiano Fava              2013   Swedish risk model 2                                    NR                        age, sex, age^2^, sex times age, heart rate, obesity, diabetes, hypertriglyceridemia, prehypertension, family history of hypertension, sedentary in spare time, problematic alcohol behavior, married or living as a couple, high-level non-manual work, smoking, 29 SNPs   NR/0.664                                                                                                                      NR                                                                                                   NR
  Nam-Kyoo Lim                2013   KoGES risk score                                        NR                        age, sex, smoking, SBP, DBP, parental hypertension, BMI                                                                                                                                                                                                                     0.79,95% CI (0.764,0.815) /NR                                                                                                 χ^2^ = 13.42, P = 0.0981                                                                             NR
  Henry                       2013   SHIP risk model                                         42                        age, mean arterial pressure, rs16998073, serum glucose and urinary albumin concentrations, interaction between age and serum glucose, interaction between rs16998073 and urinary albumin concentrations                                                                     training set 0.78 95% CI(0.74,0.82); validation set 0.79,95%CI (0.75,0.83)/NR                                                 Hosmer--Lemeshow χ^2^ = 11.82 (P = 0.16) for training set; 11.65 (P = 0.17) for the validation set   Internal (1:1) and external validation
  Yue Qi                      2014   northeastern Han Chinese genetic risk score             10                        9 SNPs                                                                                                                                                                                                                                                                      NR                                                                                                                            NR                                                                                                   NR
  Bum Ju Lee                  2014   Demographic indices risk prediction model1 for women    41                        Height, Age, NeckC, AxillaryC, RibC, WaistC, PelvicC, Rib_Hip, Waist_Hip, Pelvic_Hip, Rib_Pelvic, Axillary_Rib, Chest_Rib, Axillary_Chest, Forehead_Neck                                                                                                                    0.696 for Bayes-correlation-based feature selection;0.713 for logistic regression-correlation-based feature selection/NR      NR                                                                                                   NR
  Bum Ju Lee                  2014   Demographic indices risk prediction model2 for women    41                        Height, Age, ForeheadC, NeckC, HipC, Axillary_Hip, Axillary_Pelvic, Chest_Pelvic, Chest_Rib                                                                                                                                                                                 0.713/NR                                                                                                                      NR                                                                                                   NR
  Bum Ju Lee                  2014   Demographic indices risk prediction model3 for women    41                        Height, Weight, BMI, Age, ChestC, Forehead_Hip, Waist_Hip, Chest_Pelvic, Waist_Pelvic, Axillary_Waist, Forehead_Rib, Neck_Axillary                                                                                                                                          0.721/NR                                                                                                                      NR                                                                                                   NR
  Bum Ju Lee                  2014   Demographic indices risk prediction model 1 for men     41                        Age, ForeheadC, NeckC, AxillaryC, ChestC, RibC, WaistC, PelvicC, HipC, Rib_Hip, Waist_Hip, Rib_Pelvic, Waist_Pelvic, Chest_Waist, Forehead_Rib, Chest_Rib, Axillary_Chest, Forehead_Neck                                                                                    0.64 for Bayes-correlation-based feature selection and 0.637 for logistic regression-correlation-based feature selection/nr   NR                                                                                                   NR
  Bum Ju Lee                  2014   Demographic indices risk prediction model 2 for men     41                        Height, Age, ForeheadC, NeckC, AxillaryC, HipC, Rib_Hip, Pelvic_Hip, Neck_Pelvic, Waist_Pelvic, Chest_Waist, Chest_Rib, Neck_Chest, Axillary_Chest, Forehead_Neck                                                                                                           0.646/NR                                                                                                                      NR                                                                                                   NR
  Bum Ju Lee                  2014   Demographic indices risk prediction model 3 for women   41                        Height, ForeheadC, NeckC, AxillaryC, RibC, PelvicC, Forehead_Hip, Chest_Hip, Rib_Hip, Pelvic_Hip, Forehead_Waist, Axillary_Waist, Rib_Waist, Neck_Rib, Axillary_Rib, Chest_Rib, Forehead_Axillary, Forehead_Neck, WHtR                                                      0.652/NR                                                                                                                      NR                                                                                                   NR
  Li Guoqi                    2014   China risk prediction model 1                           NR                        age, SBP, DBP, BMI and the history of parental hypertension                                                                                                                                                                                                                 NR/0.7168                                                                                                                     Hosmer-Lemeshow χ^2^ = 3.75                                                                          NR
  Li Guoqi                    2014   China risk prediction model 2                           NR                        Age, SBP, DBP, BMI and the history of parental hypertension, TG, HDL-C                                                                                                                                                                                                      NR/0.7208                                                                                                                     Hosmer-Lemeshow χ^2^ = 3.10                                                                          NR
  Li Guoqi                    2014   China risk prediction score                             NR                        Age, SBP, DBP, BMI and the history of parental hypertension                                                                                                                                                                                                                 NR                                                                                                                            NR                                                                                                   NR
  Yun-Hee Choi                2014   marginal model                                          NR                        Intercept, Age, Gender, Smoke, Age×gender, Rs10510257 (AA), Rs10510257 (AG), Rs1047115 (GT)                                                                                                                                                                                 0.839/NR                                                                                                                      NR                                                                                                   NR
  Yun-Hee Choi                2014   conditional model                                       NR                        Intercept, Age, Gender, Smoke, Age×gender, Rs10510257 (AA), Rs10510257 (AG), Rs1047115 (GT)                                                                                                                                                                                 0.973/NR                                                                                                                      NR                                                                                                   NR
  Xiangfeng Lu                2015   InterASIA risk prediction                               NR                        Model1: Age, sex, and BMI; Model2: Model 1+smoking, drinking, pulse rate, and education; Model3: Model2 + SBP and DBP                                                                                                                                                       NR/Model1:0.650 (0.637--0.663); Model2:0.683 (0.670--0.695);Model3:0.774 (0.763--0.785)                                       NR                                                                                                   NR
  Wenchao Zhang               2015   biomarker-based risk-prediction model                   11                        inflammatory factor, blood viscidity factor, insulin resistance factor, blood pressure factor, and lipid resistance factor                                                                                                                                                  75.5% for men and 80.1% for women/nr                                                                                          NR                                                                                                   NR
  Nam-Kyoo Lim                2015   Korean genetic risk score                               4                         rs995322, rs17249754, rs1378942, rs12945290                                                                                                                                                                                                                                 NR                                                                                                                            NR                                                                                                   internal validation fivefold cross-validation
  Minoru Yamakado             2015   the PFAA index                                          19                        PFAA index 1, Leucine, Alanine, Tyrosine, asparagine, tryptophan, and Glycine; PFAA index 2, Isoleucine, Alanine, Tyrosine, phenylalanine, methionine and histidine                                                                                                         NR                                                                                                                            NR                                                                                                   NR
  Toshiaki Otsuka             2015   Japanese risk prediction model                          NR                        age, BMI, SBP and DBP, current smoking status, excessive alcohol intake, parental history of hypertension                                                                                                                                                                   NR/0.861, 95% CI(0.844, 0.877)                                                                                                Hosmer--Lemeshow χ^2^ = 15.2 P = 0.085 in validation cohort                                          internal validation Split-sample (80% vs.20%)
  Toshiaki Otsuka             2015   Japanese risk score sheet                               NR                        age, BMI, SBP and DBP, current smoking status, excessive alcohol intake and parental history of hypertension                                                                                                                                                                NR/0.858, 95% CI(0.840,0.876)                                                                                                 Hosmer--Lemeshow χ^2^ = 9.3 P = 0.41 in validation cohort                                            internal validation Split-sample (80% vs.20%)
  Joung-Won Lee               2015   Anthropometric indices risk prediction                  NR                        BMI; WaistC; waist-to-hip ratio; waist-to-height ratio                                                                                                                                                                                                                      NR                                                                                                                            NR                                                                                                   NR
  Samaneh Asgari              2015   TLGS risk prediction for ISH                            17                        Age, SBP, BMI, 2 hours post-challenge plasma glucose                                                                                                                                                                                                                        NR/0.91                                                                                                                       NR                                                                                                   NR
  Samaneh Asgari              2015   TLGS risk prediction for IDH                            17                        Age, DBP, waist circumference, marital status, gender, HDL-C                                                                                                                                                                                                                NR/0.76                                                                                                                       NR                                                                                                   NR
  Thirunavukkarasu Sathish    2016   rural India risk score                                  11                        age, sex, years of schooling, daily intake of fruits or vegetables, current smoking, alcohol use, BP, prehypertension, central obesity, history of high blood glucose                                                                                                       0.802, 95% CI(0.748--0.856)/NR                                                                                                Hosmer-Lemeshow P = 0.940                                                                            NR
  Teemu J. Niiranen           2016   genetic risk prediction model1                          32                        32 SNPs                                                                                                                                                                                                                                                                     NR                                                                                                                            NR                                                                                                   NR
  Teemu J. Niiranen           2016   genetic risk prediction model2                          32                        model 1 + age + sex                                                                                                                                                                                                                                                         NR                                                                                                                            NR                                                                                                   NR
  Teemu J. Niiranen           2016   genetic risk prediction model3                          32                        model 2 + smoking, diabetes, education, hypercholesterolemia, exercise and BMI                                                                                                                                                                                              NR/0.803                                                                                                                      NR                                                                                                   NR
  Chen, Y.                    2016   Prediction for men                                      20                        Age, BMI, SBP, DBP, gamma-glutamyl transferase, fasting blood glucose, Drinking, Age by BMI, Age by DBP                                                                                                                                                                     0.761, 95% CI(0.752--0.771)                                                                                                   NR                                                                                                   NR
  Chen, Y.                    2016   Prediction for women                                    20                        Age, BMI, SBP, DBP, fasting blood glucose, total cholesterol, neutrophil granulocyte, Drinking, Smoking                                                                                                                                                                     0.753, 95% CI(0.741--0.765)                                                                                                   NR                                                                                                   NR

NR means not reported; BP is blood pressure, SBP is systolic blood pressure and DBP is diastolic blood pressure; BMI is body mass index; AUC means the area under the receiver operating characteristic curve; CI means confidence interval; SNP is single nucleotide polymorphism; NeckC is Neck circumference; AxillaryC: Axillary circumference; RibC: Rib circumference; WaistC: Waist circumference; PelvicC: Pelvic circumference; Rib_Hip: Rib-to-pelvic circumference ratio; Waist_Hip: Waist-to-hip circumference ratio; Pelvic_Hip: Pelvic-to-hip circumference ratio; Rib_Pelvic: Rib-to-pelvic circumference ratio; Axillary_Rib: Axillary-to-rib circumference ratio; Chest_Rib: Chest-to-rib circumference ratio; Axillary_Chest: Axillary-to-chest circumference ratio; Forehead_Neck: Forehead-to-neck circumference ratio; WHtR: Waist-to-height circumference ratio.

Validation of prediction models {#sec012}
-------------------------------

The prediction models of 7 studies\[[@pone.0187240.ref009],[@pone.0187240.ref010],[@pone.0187240.ref012],[@pone.0187240.ref013],[@pone.0187240.ref015],[@pone.0187240.ref026],[@pone.0187240.ref028]\] were validated in internal cohorts through split samples, with C-statistics ranging from 0.79 to 0.9. Three models were externally validated. The SHIP risk model\[[@pone.0187240.ref015]\] from northeast Germany was validated by data from the Danish INTER99, comprising 2887 participants, and it performed well, with an AUC of 0.77 (P = 0.74) and the Hosmer--Lemeshow χ^2^ test of 40.6 (P = 2×10^−6^). The KoGES risk score from Korea was externally validated by a large nationwide Korean cohort\[[@pone.0187240.ref033]\]. The discrimination (AUC = 0.733) and calibration (Hosmer--Lemeshow χ^2^ = 14.85, P = 0.062) of this model were both good. The Framingham model was externally validated by 7 studies\[[@pone.0187240.ref012],[@pone.0187240.ref015],[@pone.0187240.ref024],[@pone.0187240.ref033]--[@pone.0187240.ref036]\] from different countries ([S3 Table](#pone.0187240.s004){ref-type="supplementary-material"}).

Meta-analysis {#sec013}
-------------

Results from pooling 35 models in the meta-analysis showed that the AUC was 0.767, 95% CI(0.742, 0.792) indicating the performance of prediction models was well. [Fig 2](#pone.0187240.g002){ref-type="fig"} shows the forest plots of analysis. As expected, the heterogeneity between studies(I-squared = 99.5%, Estimate of between-study variance Tau-squared = 0.0055) was significant(S1 file). Publication bias was evaluated with Funnel plot ([Fig 3](#pone.0187240.g003){ref-type="fig"}). The results(P\>0.05) indicated no significant publication bias.

![Forest plots of pooling 35 models.](pone.0187240.g002){#pone.0187240.g002}

![Funnel plot of publication bias.](pone.0187240.g003){#pone.0187240.g003}

Discussion {#sec014}
==========

This systematic review summarizes the current evidence regarding risk models developed to predict incident hypertension. The prediction models could help identify individuals who are more susceptible to hypertension and prioritize the underlying risk factors that lead to the incidence of hypertension. In addition, it could also help individuals with high risk for hypertension and health-care providers to take preventive interventions earlier.

Population of studies {#sec015}
---------------------

Most of these models were derived from American, European or East Asian populations; only one study was carried out in India, and the other 2 were in Iran. It is perceivable that systematic underestimation or overestimation of risk may occur when applying a model constructed from one particular cohort to a distinct ethnic population with different characteristics (the selection of predictors and the genetic background). We found that most prediction models were established in developed countries, and only a few were established in developing or undeveloped countries. Thus, it is imperative to establish reliable predictive models in those countries or regions to help reduce the incidence of hypertension and cardiovascular events caused by high blood pressure.

Predictors included {#sec016}
-------------------

The most commonly used predictors include age, BMI, SBP, DBP, etc., which are easy to obtain in clinical practice. A few studies also take blood biochemistry factors or anthropometric parameters\[[@pone.0187240.ref025],[@pone.0187240.ref027]\] as predictors ([Table 2](#pone.0187240.t002){ref-type="table"}), which are also part of the routine lab test results in a general physical examination. The biochemistry factors used as predictors include blood glucose, triglycerides, high-density lipoprotein cholesterol (HDL-C), and fibrinogen. It has been reported that the level of blood glucose is associated with high blood pressure\[[@pone.0187240.ref037]\]. Triglyceride, cholesterol and HDL-C are also known to contribute to blood hyperviscosity\[[@pone.0187240.ref038]\] and vascular sclerosis, which could lead to the rise of the BP. Since hypertension is also considered as a metabolic disease, the changes of blood biochemical factors could provide important and valuable information for the accuracy of certain hypertension prediction models.

It is well known that the interaction between environmental and genetic factors contributes to the development of hypertension. Theoretically, the prediction models should contain both environmental and genetic predictors. Most of the SNPs used to construct GRS were from GWAS ([S2 Table](#pone.0187240.s003){ref-type="supplementary-material"}). In the Finnish study\[[@pone.0187240.ref016]\], results showed that GRS were significantly associated with BP but weakly associated with BP increase and incident hypertension; in contrast, in Hispanic Americans\[[@pone.0187240.ref011]\], GRS was constructed by 2 SNPs on chromosome 3 alone, and when GRS was added into the model, the improvement of predicting capability measured by the AUC was minor. In a Korean population\[[@pone.0187240.ref026]\], GRS was constructed by 4 SNPs based on GWAS, which was independently associated with the risk of incident hypertension. Among the 4 SNPs, rs17249754 was the same predictor as that selected in 2 Chinese genetic studies\[[@pone.0187240.ref019],[@pone.0187240.ref021]\], and rs1378942 was the same as that used in the Swedish genetic study\[[@pone.0187240.ref014]\]. However, adding GRS into models with traditional risk factors did not significantly improve the discrimination ability. In the Swedish study\[[@pone.0187240.ref014]\], when adding cGRS (derived from a simple, unweighted count method) into the traditional model, AUC was marginally, but not significantly, improved (from 0.662 to 0.664). In the 29 SNPs that constructed cGRS, one (rs1378942) was the same as that selected in Korean study\[[@pone.0187240.ref026]\] and two (rs16998073, rs11191548) were the same as those selected in 2 Chinese studies\[[@pone.0187240.ref019],[@pone.0187240.ref021]\]. A couple of factors may contribute to these unfavorable observations. First, since hypertension is a known multigene disease, a limited number of SNPs as representative predictors may not fully reflect the overall contribution and weight of all genetic variants. Second, it is possible that some of those included SNPs were selected without fully considering their potential interactions with other genetic variants or environmental factors.

In contrast, in a Chinese study\[[@pone.0187240.ref021]\], adding GRS constructed by 22 carefully selected SNPs to the traditional predictors produced an ideal result, as the C-index value improved significantly (C-index change = 0.3%--0.5%; all *p* \< 0.05). Among the 22 uncorrelated (*r*^2^ \< 0.5) SNPs, 10 were associated with SBP or DBP from published GWAS data obtained from an East Asian population, and 19 SNPs had been identified and verified in a Chinese population. These results clearly suggested that the contribution and value of GRS to a hypertension prediction model heavily depends on the selection of SNPs. Since hypertension is a disease of polygenic inheritance, the selection of SNPs used for GRS construction is thus critical. Using GWAS results as the only source for SNP selection is inadequate, as the characteristics of SNPs obtained from one particular GWAS may not necessarily be suitable for other ethnic populations. More appropriate SNP selection should come from the genetic research results in the same ethnic group. Other SNP selection considerations for GRS construction should include a sufficient number of SNPs, causal relationship between the select genes and disease development, gene-gene or gene-environment interactions, and proper statistical methods to include or exclude gene loci.

At the present stage, genetic markers for predicting hypertension can be of great interest for researchers and basic scientists (and possibly for drug companies), but may not hold much interest for patients. Once genetic factors are included in prediction models, patients cannot use the model for self-assessment, clinicians could face problems explaining the model, and cost for genetic tests can be high. These problems may be resolved with the development of gene-function and gene-sequencing research.

Model validation {#sec017}
----------------

Seven studies validated their prediction models using internal validation. All studies indicated good discriminatory ability and calibration, suggesting that the models could be applied in the original population with satisfactory performance. A Framingham prediction model was validated in external populations by 7 studies ([S3 Table](#pone.0187240.s004){ref-type="supplementary-material"}). It performed well in a study of African-American and Caucasians in the US\[[@pone.0187240.ref035]\], a German study\[[@pone.0187240.ref015]\] and a British study\[[@pone.0187240.ref012]\]. In a large nationwide Korean cohort,\[[@pone.0187240.ref033]\]the AUC was acceptable, but this model underestimated hypertension incidence (*p*\<0.001) in Korea. In the Multi-Ethnic Study of Atherosclerosis (MESA)\[[@pone.0187240.ref034]\], including Caucasian, African-American, Hispanic, and Asian (primarily of Chinese descent) participants, the Framingham model showed better discrimination ability than SBP alone or age-specific DBP categories. However, the difference between the observed and the predicted hypertension risks (Hosmer-Lemeshow goodness of fit *p*\<0.001) in the MESA study was significant. In contrast, the discrimination (C-statistics = 0.5 to 0.6) and calibration ability (*p*\<0.0001) in rural Chinese was poor\[[@pone.0187240.ref036]\], whereas poor agreement (χ^2^ = 29.73, *p* = 0.0002) underestimated the risk of hypertension in Koreans\[[@pone.0187240.ref024]\]. The distinct performance in different populations was partially attributed to the various levels of risk predictors and inherited variables. These differences suggested that a model derived from one particular population could not be directly applied to a distinct population, and the fittest model for one particular population is that derived from the same population.

Heterogeneity {#sec018}
-------------

The meta-analysis showed the heterogeneity was significant. The included variables, study designs, number of participants, populations, statistical methods, and follow-up times were different from each other, which might be the source of heterogeneity. We attribute this to the specialization of prediction models, which need to be built for various populations, because no one model could be applied to all people.

Clinical implications {#sec019}
---------------------

Currently, a large issue regarding hypertension prediction models/scores is that nobody uses these scores in daily life or clinical practice beyond research publications. Some people even question whether hypertension needs to be predicted, as it can be easily measured with noninvasive, cheap, and accessible methods. The function of these models is not only to predict the occurrence of hypertension but, more meaningfully, to remind patients and physicians to pay attention to BP. What is more, it has been proved that the process of progression from normotensive or prehypertension to hypertension can be delayed or prevented by proper and timely clinical interventions. It is urgent and meaningful for people to conduct timely interventions. The importance of prediction models/scores needs to be widely disseminated by authorities or the media to promote their application.

Strengths and limitations of existing models {#sec020}
--------------------------------------------

Most of the current predictors are data commonly collected in routine clinical practice, which are relatively easier for both health-care providers and patients to access. Some models are in the form of risk scores, which may still have room to improve but are also convenient to use in routine clinical practice. Furthermore, several models took GRS into account, which could contribute significantly to their prediction accuracy of hypertension. Since the performance of all these prediction models was accepted as good, the application of these models in clinical practice is very promising.

In contrast, several limitations of these prediction models are also noted. First, since not all these studies were specifically designed or conducted for generating prediction models, the clinical data collection may not be complete, and quality of data collected to inform these models also varies greatly; thus, prediction accuracy is a concern. Second, the enrollment number of participants was low in some studies and may not represent the true characteristics of the general population. Third, the various levels of risk predictors and inherited variables between populations made the models inapplicable for other general people. Fourth, a justified method in selecting the suitable SNPs is lacking. Fifth, since most of the BP data were obtained in hospital or clinic settings, the "white coat effect" may influence the outcome of the BP measurement. Sixthly, none of these models have been shown to improve outcomes in prospective research. Lastly, only a few models were indeed validated by internal cohorts, and only 3 were validated in external cohorts. The validation in internal cohort is more or less considered as a repeat of the original cohort and thus may be overoptimistic in its prediction performance results.

Conclusion {#sec021}
==========

Recently, more and more hypertension prediction models have been reported in different countries and among various ethnic populations. Most of the reported predictors are commonly used in routine clinical practice, and the role of genetic factors is earning more attention. However, the incorporation of genetic variation does not improve the performance significantly for all models. The selection of gene loci is critical, and a justified method in selecting the suitable SNPs is needed. The current reported models have satisfying discrimination and calibration ability, but the validation of these models is still insufficient, which is a critical and required step prior to their broad application in daily clinical practice.

Perspective of future research {#sec022}
------------------------------

It is obvious that the current prediction models might not be perfect, but they do provide a solid foundation for future studies. Of course, more studies on prediction models of hypertension should be conducted with large enrollment numbers, complete data collection, experienced or well-trained investigators, and appropriate statistical analysis. With the development of genetic research, more hypertension-associated SNPs will be found, and a standard protocol in gene loci selection as a candidate prediction factor will be needed. Indeed, before any models are used as guidelines, they need to be validated in various cohorts and adjusted accordingly.

Supporting information {#sec023}
======================

###### Begg's and Egger's publication bias plot.

(TIF)
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Click here for additional data file.

###### PRISMA 2009 checklist.

(DOC)
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###### SNPs of GRS.

SNP: single nucleotide polymorphism; GWAS: Genome Wide Association Study; NR: not reported. Rs1378942 was chosen in both Sweden and Korean studies; rs17249754 in Korean and 2 Chinese studies; rs11191548 and rs16998073 from Sweden were the same in two Chinese studies; in two Chinese studies, 7 SNPs (rs17030613, rs16849225, rs1173766, rs11066280, rs35444, rs880315 and rs17249754) were the same.

(DOCX)
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Click here for additional data file.

###### External validation of the Framingham model.

AUC means the area under the receiver operating characteristic curve; CI means confidence interval; JNC---VII definition means the definition of hypertension is based on the Joint National Committee (JNC)---VII definition of hypertension (i.e., SBP/DBP ≥140/90 mmHg or use of antihypertension medications); NR means not reported. First author and year represent study.

(DOCX)
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###### Results of meta-analysis and publication bias test.
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###### 

Click here for additional data file.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: ‡ These authors are co-first authors on this work.
